Arrhythmias & electrophysiology

Simplified 3-ganglionated plexus ablation for the treatment of recurrent vasovagal syncope and functional bradyarrhythmia

Heart RhythmPublished prospective, observational study

Authors' conclusion

A simplified 3-GP ablation strategy resulted in similar autonomic denervation and clinical outcomes compared with an extended ablation approach.

Study context

Population
Patients with recurrent VVS, extrinsic atrioventricular block (AVB), or sinus node dysfunction (SND) undergoing cardioneuroablation
Participants
58 patients
Exposure
Simplified 3-GP ablation strategy vs extensive ablation approach
Outcome
Relative HR increase after the atropine test; syncope or pacemaker-free survival
Follow-up
Baseline and 6 months; 19.1 (9.2-26.8) months

Main finding

As reported in the abstract

Syncope or pacemaker-free survival

log-rank P = .467

OutcomeGroup AGroup BP value
Relative HR increase following CNA9.9% [4.1-19.0]5.6% [2.8-8.4]P = 0.069
Relative HR increase at 6 months24.8% [15.0-37.2]19.9% [16.8-25.4]P = 0.277

Observational data: associations, not effects.

Further findings

OutcomeP value
Procedural time and fluoroscopy timeGroup A vs group B · procedural time significantly shorter in the only 3-GP groupP = 0.036
Procedural time and fluoroscopy timeGroup A vs group BP = 0.015
  • Procedural time and fluoroscopy time: fluoroscopy time significantly shorter in the only 3-GP group

HR variability parameters and autonomic functional tests

No significant differences in most HR variability parameters or autonomic functional tests

SF-36 quality-of-life score

Significant improvement in both groups, physical function
P < 0.001
Significant improvement in both groups, health change
P < 0.001

Original publication

Simplified 3-ganglionated plexus ablation for the treatment of recurrent vasovagal syncope and functional bradyarrhythmia. Heart Rhythm. Published 30 April 2025. doi:10.1016/j.hrthm.2025.04.052

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.